EAM Investors’s Sensus Healthcare SRTS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-92,103
Closed -$637K 359
2024
Q4
$637K Sell
92,103
-4,964
-5% -$36.4K 0.09% 240
2024
Q3
$563K Sell
97,067
-18,007
-16% -$109K 0.08% 226
2024
Q2
$613K Buy
+115,074
New +$529K 0.1% 216
2022
Q4
Sell
-327,261
Closed -$4.1M 335
2022
Q3
$4.1M Sell
327,261
-1,719
-0.5% -$20.5K 0.89% 8
2022
Q2
$2.53M Buy
328,980
+5,665
+2% +$47.6K 0.62% 36
2022
Q1
$3.27M Buy
323,315
+122,988
+61% +$1.12M 0.61% 33
2021
Q4
$1.45M Buy
+200,327
New +$1.1M 0.24% 205
2019
Q2
Sell
-69,774
Closed -$490K 311
2019
Q1
$490K Buy
+69,774
New +$539K 0.12% 241

Other funds holding SRTS

EAM Investors's SRTS Position: Q1 2025 in Review

EAM Investors sold out of Sensus Healthcare (SRTS) in Q1 2025, closing a stake of 92,103 shares — an estimated $637K sold.

EAM Investors first reported a position in SRTS in Q1 2019 and held it in 8 quarters. The position peaked at $4.1M in Q3 2022. 53 funds tracked by Wall St. Rank hold SRTS as of Q1 2025.

  • EAM Investors reported no remaining Sensus Healthcare position as of Q1 2025 after selling out during the quarter.
  • EAM Investors sold 92,103 Sensus Healthcare shares in Q1 2025, an estimated $637K.
  • EAM Investors first reported a position in Sensus Healthcare in Q1 2019 and held it in 8 quarters.
  • EAM Investors's Sensus Healthcare position peaked at $4.1M in Q3 2022.
  • 53 funds tracked by Wall St. Rank held Sensus Healthcare as of Q1 2025.

Based on EAM Investors's 13F filing for Q1 2025, filed 13 May 2025.